Adult Care in Cystic Fibrosis
1Centre for Experimental Medicine, Queen's University, Belfast, Northern Ireland, United Kingdom.
Insights
Cystic fibrosis (CF) care is shifting to adults, necessitating new strategies. Adapting healthcare systems and multidisciplinary teams is crucial for improving adult CF patient quality of life and survival.
Area of Science:
- Pulmonology and Adult Medicine
- Healthcare Systems Research
Background:
- Cystic fibrosis (CF) prevalence is increasing in adults, particularly in developed nations.
- Adults now represent the majority of the CF population, with most morbidity and mortality occurring in this age group.
- Emerging CFTR modulator therapies may further increase adult lifespan and complexity of care.
Purpose of the Study:
- To highlight the evolving demographic of cystic fibrosis towards an adult-predominant population.
- To emphasize the critical need for adapting healthcare models to meet the complex needs of adult CF patients.
- To underscore the importance of multidisciplinary care and quality of life for aging adults with CF.
Main Methods:
- This is a conceptual and review-based abstract, not detailing specific experimental methods.
- Analysis of current trends in CF demographics and healthcare delivery.
- Synthesis of expert opinion on future care requirements for adult CF patients.
Main Results:
- Adults are increasingly the primary demographic for cystic fibrosis care.
- Existing healthcare models require significant adaptation to manage the growing adult CF population.
- Adult CF patients face complex co-morbidities, including age-related diseases, alongside CF.
Conclusions:
- Maintaining quality of life and maximizing survival are paramount for adults with CF.
- Adaptable, multidisciplinary teams are essential, integrating diverse specialties beyond lung health.
- New healthcare delivery models are urgently needed to address the complex, aging adult CF population.
Abstract:
Cystic fibrosis (CF) is now more common in adults than children in countries with well-developed health care systems. The number of adults continues to increase and will further increase if the new cystic fibrosis transmembrane conductance regulator (CFTR) modulators are disease modifying. Most of the complex morbidity and almost all the mortality of CF occur in adults and will increasingly follow this pattern even with new effective modulator therapies. Maintaining good quality of life including social functioning and maximizing survival for adults are the key priorities. This requires a highly knowledgeable and adaptable multidisciplinary team, which, though focused on maintaining lung health, requires an increasing range of other disciplines and specialties to maximize well-being. Changes in health care systems will require current models of care to adapt to provide care for the large number of adult patients. With increasing survival and age, many are likely to have both CF morbidities and additional diseases of aging. New models are needed for health care delivery for this expanding population with complex medical conditions.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Restorative Care
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Continuing Care


